Guardant Health (MEX:GH) Days Inventory: 73.75 (As of Mar. 2026) — Near Median


MEX:GH Guardant Health Inc MEX:GH
13 GF Score
Price MXN2,590.00
GF Value MXN934.61
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Guardant Health Days Inventory?

Guardant Health MEX:GH 13 Days Inventory is 73.75 as of Mar. 2026, which is 4% below its 10-year median of 77.01. GuruFocus rates MEX:GH with a GF Score™ of 13/100 and a GF Value™ of MXN934.61 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Guardant Health ranks worse than 57.06% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Guardant Health's Average Total Inventories for the three months ended in Mar. 2026 was MXN1,529 Mil. Guardant Health's Cost of Goods Sold for the three months ended in Mar. 2026 was MXN1,892 Mil. Hence, Guardant Health's Days Inventory for the three months ended in Mar. 2026 was 73.75.

The historical rank and industry rank for Guardant Health's Days Inventory or its related term are showing as below:

MEX:GH' s Days Inventory Range Over the Past 10 Years
Min: 45.68   Med: 77.01   Max: 96.05
Current: 81.15

During the past 10 years, Guardant Health's highest Days Inventory was 96.05. The lowest was 45.68. And the median was 77.01.

MEX:GH's Days Inventory is ranked worse than
57.06% of 177 companies
in the Medical Diagnostics & Research industry
Industry Median: 70.8 vs MEX:GH: 81.15

Guardant Health's Days Inventory declined from Mar. 2025 (91.42) to Mar. 2026 (73.75).

Inventory Turnover measures how fast the company turns over its inventory within a year. Guardant Health's Inventory Turnover for the three months ended in Mar. 2026 was 1.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Guardant Health's Inventory-to-Revenue for the three months ended in Mar. 2026 was 0.28.


Guardant Health  (MEX:GH) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Guardant Health's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Guardant Health's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Guardant Health Days Inventory Related Terms


Guardant Health Days Inventory Historical Data

* Premium members only.

The historical data trend for Guardant Health's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Days Inventory Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.25 97.92 97.43 76.52 87.96

Guardant Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.42 94.39 86.18 81.66 73.75

MEX:GH vs LH, DGX, MEDP: Days Inventory Comparison

For the Diagnostics & Research subindustry, Guardant Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardant Health Days Inventory vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Days Inventory distribution charts can be found below:

* The bar in red indicates where Guardant Health's Days Inventory falls into.


MEX:GH
13GF Score
Guardant Health Inc MEX:GH
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Guardant Health's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (1482.486 + 1546.257) / 2 ) / 6284.116*365
=1514.3715 / 6284.116*365
=87.96

Guardant Health's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (1546.257 + 1512.06) / 2 ) / 1891.972*365 / 4
=1529.1585 / 1891.972*365 / 4
=73.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 73.75 mean?
Guardant Health (MEX:GH) has a Days Inventory of 73.75 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Guardant Health and its competitors. This is near median its historical median of 77.01. Over the past decade, Guardant Health's Days Inventory has ranged from 45.68 to 96.05. According to the industry distribution chart, Guardant Health ranks #101 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 57.1%.
Is Guardant Health's Days Inventory too high?
Guardant Health's current Days Inventory of 73.75 is near median its 10-year median of 77.01. Over the past 10 years, this metric has ranged from a low of 45.68 to a high of 96.05. The Medical Diagnostics & Research industry median Days Inventory is 70.80. Guardant Health's value of 73.75 is 4.2% above this industry median. Based on the distribution chart, Guardant Health ranks #101 out of 177 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Guardant Health has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Days Inventory compare to LH and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Guardant Health ranks #101 out of 177 companies for Days Inventory. This places Guardant Health in the lower half of its industry. The industry median Days Inventory is 70.80. Guardant Health's value of 73.75 is 4.2% above this benchmark. Historically, Guardant Health's own Days Inventory has ranged from 45.68 to 96.05 over the past decade. While the company's 10-year median is 77.01 vs. the industry median of 70.80, Guardant Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 70.80, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardant Health's current Days Inventory of 73.75 is 4.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Guardant Health and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 70.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardant Health's current Days Inventory is 73.75, which is near median its own 10-year median of 77.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (MEX:GH) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN934.61, compared to a current price of MXN2,590.00 — trading 177.1% above its estimated fair value. The current Days Inventory is 73.75, which is near median its 10-year median of 77.01 and 4.2% above the Medical Diagnostics & Research industry median of 70.80. Guardant Health's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Days Inventory is 73.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,590.00 is trading 177.1% above its estimated GF Value™ of MXN934.61. GuruFocus considers Guardant Health to be Significantly Overvalued.

Key valuation signals for MEX:GH:

  • Days Inventory: 73.75 (near median its 10-year median of 77.01)
  • GF Value™: MXN934.61 vs. price of MXN2,590.00 (177.1% above fair value)
  • GF Score™: 13/100 with 3 warning signs
  • Industry Position: 4.2% above the Medical Diagnostics & Research median (#101 of 177)

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
13GF Score

Get the complete analysis for MEX:GH

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,590.00
Price
MXN934.61
GF Value